These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19336760)

  • 1. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
    Sulahian R; Cleaver O; Huang LJ
    Blood; 2009 May; 113(21):5287-97. PubMed ID: 19336760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
    Bulut GB; Sulahian R; Yao H; Huang LJ
    Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.
    Huang LJ; Shen YM; Bulut GB
    Br J Haematol; 2010 Mar; 148(6):844-52. PubMed ID: 20096014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
    Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
    Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
    Singh S; Verma R; Pradeep A; Leu K; Mortensen RB; Young PR; Oyasu M; Schatz PJ; Green JM; Wojchowski DM
    PLoS One; 2012; 7(1):e29064. PubMed ID: 22253704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
    Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
    J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras.
    Gross M; Ben-Califa N; McMullin MF; Percy MJ; Bento C; Cario H; Minkov M; Neumann D
    Br J Haematol; 2014 May; 165(4):519-28. PubMed ID: 24533580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of primary familial and congenital polycythemia.
    Kralovics R; Prchal JT
    Am J Hematol; 2001 Oct; 68(2):115-21. PubMed ID: 11559951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
    Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
    Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
    Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
    Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor.
    Miura O; Nakamura N; Ihle JN; Aoki N
    J Biol Chem; 1994 Jan; 269(1):614-20. PubMed ID: 8276859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
    Kralovics R; Sokol L; Prchal JT
    J Clin Invest; 1998 Jul; 102(1):124-9. PubMed ID: 9649565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
    Ueda F; Tago K; Tamura H; Funakoshi-Tago M
    J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
    Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
    PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial polycythemia due to truncations of the erythropoietin receptor.
    Forget BG; Degan BA; Arcasoy MO
    Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
    Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.
    Watowich SS; Xie X; Klingmuller U; Kere J; Lindlof M; Berglund S; de la Chapelle A
    Blood; 1999 Oct; 94(7):2530-2. PubMed ID: 10498627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.